Sponsor Pipeline

Arrowhead Pharmaceuticals Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
14
Active Trials
8
Recruiting
7
Phase 3
4
Disease Areas
5
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-13 NCT06822790
Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia
Trial sites reduced: 294 -> 255 locations
2026-08-13 NCT07037771
A Phase 3 Study of Zodasiran in Adolescent and Adult Subjects With Homozygous Familial…
Enrollment closed, study ongoing
2026-08-13 NCT07037771
A Phase 3 Study of Zodasiran in Adolescent and Adult Subjects With Homozygous Familial…
Enrollment increased: 60 -> 70 participants
2026-07-24 NCT06880770
Study of Plozasiran in Adults With Severe Hypertriglyceridemia at Risk of Acute…
Trial sites expanded: 95 -> 102 locations
2026-07-23 NCT07662096
A First-In-Human Study of ARO-033 in Adult Participants
Recruitment opened
Active Trials by Phase
Phase 3
7
Phase 2
1
Phase 1/2
4
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06880770 Study of Plozasiran in Adults With Severe Hypertriglyceridemia at Risk of Acute… Severe Hypertriglyceridemia Recruiting
NCT06822790 Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia Hypertriglyceridemia Recruiting
NCT07473843 Study of Zodasiran in Adolescent Participants With Homozygous Familial… Homozygous Familial Hypercholesterolemia Not Yet Recruiting
NCT06347133 Phase 3 Study of Plozasiran in Adults With Hypertriglyceridemia Hypertriglyceridemia Active, Not Recruiting
NCT06347003 Study of Plozasiran (ARO-APOC3) in Adults With Severe Hypertriglyceridemia Severe Hypertriglyceridemia Active, Not Recruiting
NCT06347016 Study of Plozasiran in Adults With Severe Hypertriglyceridemia Severe Hypertriglyceridemia Active, Not Recruiting
NCT07037771 A Phase 3 Study of Zodasiran in Adolescent and Adult Subjects With Homozygous Familial… Homozygous Familial Hypercholesterolemia Active, Not Recruiting
Phase 2
NCT07241546 Study of Inhaled ARO-RAGE in Allergen-induced Mild Asthma Asthma Recruiting
Phase 1/2
NCT07221344 Study of ARO-MAPT-SC in Healthy Participants and Participants With Early Alzheimer's… Alzheimer Disease Recruiting
NCT06700538 A First-In-Human Study of ARO-INHBE in Adults With Obesity With and Without Type 2… Obesity Recruiting
NCT06937203 A First-In-Human Study of ARO-ALK7 in Adults With Obesity With and Without Type 2… Obesity Recruiting
NCT07223658 Study of ARO-DIMERPA in Adult Participants With Mixed Hyperlipidemia Hyperlipidemia; Mixed Recruiting
Phase 1
NCT07662096 A First-In-Human Study of ARO-033 in Adult Participants Healthy Participants Recruiting
NCT06672445 Study of ARO-ATXN2 Injection in Adults With Spinocerebellar Ataxia Type 2 Spinocerebellar Ataxia Type 2 Active, Not Recruiting
Disease Areas
Get alerts when Arrowhead Pharmaceuticals's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free